S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
GDRX · GoodRx Holdings, Inc. Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
GoodRx Holdings Inc (GDRX)
NASDAQ NMS - GLOBAL MARKET
Health Care
$3.57
+0.05
(+1.42%)
● At close: October 21 at 4:00:00 PM EDT
$3.56
-0.01
(-0.28%)
Overnight:
8:08:30 PM EDT
DAY'S RANGE
$3.57
$3.46
$3.63
52-WEEK RANGE
$3.57
$1.77
$4.05
What's happening
- GDRX is up 1.42% today, trading at $3.57. — Live quote
- Volume today (117,841) is well below its 3-month average of 1,232,180. (Finnhub fundamentals)
- Reports earnings on 2026-11-10 (before market open), 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $0.08 actual vs. $0.08 estimated (-1.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 6
Hold 9
Sell 2
Strong sell 0
Aggregate ratings for 2026-10-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
GDRX
+29.89%
vs S&P 500
+17.11%
1-YEAR RETURN
GDRX
-11.56%
vs S&P 500
-26.12%
6-MONTH RETURN
GDRX
+49.79%
3-MONTH RETURN
GDRX
+16.56%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.08
Est. $0.08
MISS -1.0%
2026-04-26 (Q1 2026)
$0.07
Est. $0.07
MISS -4.6%
2026-01-26 (Q4 2025)
$0.09
Est. $0.09
MISS -3.6%
2025-10-26 (Q3 2025)
$0.08
Est. $0.09
MISS -13.4%
Valuation Measures & Ratios
Enterprise Value4$1.38B
Forward P/E510.07
PEG Ratio6-29.31
Price / Sales (TTM1)1.52
Price / Book71.51
EV4 / Revenue1.76
EV4 / EBITDA8.45
Profit Margin2.07%
Operating Margin9.54%
Return on Equity (ROE8)2.61%
Return on Assets (ROA9)0.92%
Avg Volume (3M)1,232,180
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.23B | — | — | $1.60B | $1.62B |
| P/E | 51.85 | — | — | 46.32 | 78.48 |
| Price/Sales | 1.55 | — | — | 2.00 | 2.04 |
| Price/Book | 1.89 | — | — | 2.49 | 2.48 |
| EV/Revenue | 1.79 | — | — | 2.26 | 2.28 |
| ROE | 3.65% | — | — | 5.37% | 3.16% |
| ROA | 1.01% | — | — | 2.62% | 1.60% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short4,155,510
Change from Prior Settlement-12.07%
% of Float—
Days to Cover (Short Ratio)5.37
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-15; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -1.3% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 2.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -11.6%. Finnhub market metrics ↗
- Trailing P/E is 73.4, a high price relative to reported earnings. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on GDRX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $200.4M | $194.0M | $196.0M | $203.1M | $203.0M | $195.3M | $200.6M | $197.9M |
| Operating income | $23.6M | $14.0M | $14.6M | $26.8M | $23.4M | $20.4M | $19.9M | $7.4M |
| Net income | $8.5M | $1.2M | $1.1M | $12.8M | $11.1M | $4.0M | $6.7M | -$1.0M |
| EPS (diluted) | $0.02 | $0.00 | $0.00 | $0.04 | $0.03 | $0.01 | $0.02 | $0.00 |
| EPS (basic) | $0.03 | $0.00 | $0.00 | $0.04 | $0.03 | $0.01 | $0.02 | $0.00 |
| Operating margin | $12 | $7 | $7 | $13 | $12 | $10 | $10 | $4 |
| Net margin | $4 | $1 | $1 | $6 | $5 | $2 | $3 | -$1 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.34B | $2.02B | $1.40B | $1.33B | $1.32B | $1.30B | $1.39B | $1.35B |
| Total liabilities | $1.70B | $1.40B | $787.8M | $724.8M | $675.7M | $640.9M | $663.4M | $658.4M |
| Stockholders' equity | $647.6M | $622.0M | $616.3M | $600.7M | $643.0M | $654.3M | $724.7M | $696.4M |
| Total current assets | $1.60B | $1.27B | $643.1M | $565.5M | $550.6M | $540.2M | $659.3M | $626.8M |
| Total current liabilities | $1.16B | $859.2M | $246.0M | $181.9M | $130.9M | $103.4M | $123.9M | $114.4M |
| Cash & equivalents | $296.1M | $235.7M | $261.8M | $273.5M | $281.3M | $301.0M | $448.3M | $423.8M |
| Accounts receivable | $182.1M | $232.7M | $235.7M | $203.7M | $189.0M | $160.1M | $145.9M | $130.8M |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $11.5M | $11.7M | $12.3M | $11.3M | $10.7M | $11.5M | $12.7M | $13.6M |
| Goodwill | $430.3M | $430.3M | $430.3M | $421.7M | $421.7M | $421.7M | $410.8M | $410.8M |
| Intangible assets | $58.3M | $61.2M | $64.1M | $62.8M | $65.6M | $68.4M | $52.1M | $54.1M |
| Other non-current assets | $28.2M | $29.6M | $29.1M | $23.3M | $23.9M | $22.8M | $23.5M | $34.9M |
| Accounts payable | $8.9M | $14.5M | $19.4M | $28.7M | $25.4M | $15.3M | $14.1M | $12.4M |
| Deferred revenue (current) | $8.8M | $8.6M | $6.7M | $6.3M | $6.1M | $6.3M | $6.0M | $6.3M |
| Short-term debt | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $3.8M |
| Long-term debt | $481.6M | $482.4M | $483.3M | $484.1M | $485.0M | $485.8M | $486.7M | $487.6M |
| Other non-current liabilities | $8.9M | $8.7M | $8.7M | $7.6M | $7.0M | $6.9M | $6.8M | $8.8M |
| Common stock & paid-in capital | $34.0K | $34.0K | $34.0K | $34.0K | $35.0K | $36.0K | $38.0K | $38.0K |
| Retained earnings | -$1.40B | -$1.41B | -$1.41B | -$1.42B | -$1.42B | -$1.43B | -$1.44B | -$1.45B |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.8M | $11.8M | $32.9M | $76.0M | $49.6M | $9.4M | $44.7M | $86.9M |
| Investing cash flow | -$14.4M | -$21.6M | -$31.8M | -$18.0M | -$18.3M | -$51.9M | -$16.6M | -$15.9M |
| Financing cash flow | -$6.0M | -$16.3M | -$12.8M | -$65.8M | -$50.9M | -$104.9M | -$3.5M | -$172.1M |
| Free cash flow | $80.5M | $10.7M | $31.6M | $74.3M | $49.2M | $9.3M | $44.6M | $86.5M |
| Capital expenditures | $362.0K | $1.1M | $1.2M | $1.7M | $390.0K | $142.0K | $162.0K | $403.0K |
| Share-based compensation | $16.6M | $16.5M | $17.9M | $18.1M | $21.4M | $19.2M | $21.0M | $26.4M |
| Deferred income taxes | $5.7M | $4.1M | $12.0M | $8.1M | $0 | $0 | -$11.3M | -$642.0K |
| Change in accounts receivable | -$50.6M | -$3.0M | $30.2M | $14.7M | $28.9M | $14.2M | $15.1M | -$31.0M |
| Change in accounts payable | -$4.9M | -$4.9M | -$10.5M | $11.0M | $3.3M | $286.0K | $7.3M | -$5.2M |
| Other investing activities | — | — | $2.5M | — | — | — | $0 | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | $2.0M | $12.6M | $9.4M | $61.1M | $46.0M | $99.9M | $188.0K | $5.4M |
| Debt issued | — | — | $0 | $0 | — | — | $0 | $472.0M |
| Debt repaid | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $0 | $633.8M |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $796.9M | $792.3M | $750.3M | $766.6M | $745.4M |
| Operating income | $87.5M | $65.8M | -$27.0M | $1.7M | $13.4M |
| Net income | $30.4M | $16.4M | -$8.9M | -$32.8M | -$25.3M |
| EPS (diluted) | $0.09 | $0.04 | $-0.02 | $-0.08 | $-0.06 |
| EPS (basic) | $0.09 | $0.04 | $-0.02 | $-0.08 | $-0.06 |
| Operating margin | $11 | $8 | -$4 | $0 | $2 |
| Net margin | $4 | $2 | -$1 | -$4 | -$3 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.40B | $1.39B | $1.59B | $1.60B | $1.61B |
| Total liabilities | $787.8M | $663.4M | $826.8M | $789.8M | $775.9M |
| Stockholders' equity | $616.3M | $724.7M | $762.0M | $814.8M | $831.7M |
| Total current assets | $643.1M | $659.3M | $872.8M | $919.7M | $1.09B |
| Total current liabilities | $246.0M | $123.9M | $122.6M | $76.3M | $81.1M |
| Cash & equivalents | $261.8M | $448.3M | $672.3M | $757.2M | $941.1M |
| Accounts receivable | $235.7M | $145.9M | $143.6M | $117.1M | $118.1M |
| Property, plant & equipment | $12.3M | $12.7M | $15.9M | $19.8M | $21.6M |
| Goodwill | $430.3M | $410.8M | $410.8M | $412.1M | $329.7M |
| Intangible assets | $64.1M | $52.1M | $60.9M | $119.9M | $88.8M |
| Other non-current assets | $29.1M | $23.5M | $37.8M | $27.2M | $6.0M |
| Accounts payable | $19.4M | $14.1M | $36.3M | $17.7M | $17.5M |
| Deferred revenue (current) | $6.7M | $6.0M | $7.1M | $7.9M | $6.9M |
| Short-term debt | $5.0M | $5.0M | $8.8M | $7.0M | $7.0M |
| Long-term debt | $483.3M | $486.7M | $647.7M | $651.8M | $655.9M |
| Other non-current liabilities | $8.7M | $6.8M | $8.2M | $7.6M | $5.4M |
| Common stock & paid-in capital | $34.0K | $38.0K | $40.0K | $40.0K | $40.0K |
| Retained earnings | -$1.41B | -$1.44B | -$1.46B | -$1.45B | -$1.42B |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $167.9M | $183.9M | $138.3M | $146.8M | $178.8M |
| Investing cash flow | -$120.0M | -$70.3M | -$55.8M | -$210.5M | -$178.7M |
| Financing cash flow | -$234.5M | -$337.5M | -$167.4M | -$120.2M | -$30.5M |
| Free cash flow | $164.4M | $182.7M | $137.2M | $142.8M | $174.2M |
| Capital expenditures | $3.5M | $1.2M | $1.0M | $4.0M | $4.6M |
| Share-based compensation | $76.6M | $99.0M | $104.8M | $120.2M | $160.5M |
| Deferred income taxes | $20.1M | -$11.9M | -$65.6M | -$497.0K | $12.9M |
| Change in accounts receivable | $88.0M | $2.3M | $26.5M | -$1.4M | $43.9M |
| Change in accounts payable | $4.1M | -$15.8M | $12.0M | -$874.0K | $4.2M |
| Other investing activities | $2.5M | $0 | $0 | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | $216.4M | $158.8M | $104.0M | $101.7M | $0 |
| Debt issued | $0 | $472.0M | $0 | $0 | $0 |
| Debt repaid | $5.0M | $639.0M | $5.3M | $7.0M | $7.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding GDRX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-15 to 2026-10-15
Recent transactions
- Insiders have net sold 2,760,995 shares over the last 182 days, across 0 purchases and 14 sales.
- Most recent: Fengler Justin (See Remarks) — Option exercise of 32,490 shares on 2026-10-15.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)2,760,995 sh(14 txns)
Net Shares-2,760,995
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Fengler Justin | See Remarks | Option exercise | 2026-10-15 | 32,490 |
| Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 2026-10-15 | 5,793 |
| Barnes Wendy Lynn | See Remarks | Option exercise | 2026-10-15 | 115,149 |
| FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 2026-08-26 | 213,401 |
| McGinnis Christopher A | See Remarks | Option exercise | 2026-07-15 | 36,988 |
| REY-GIRAUD AGNES | Director | Grant / award | 2026-06-16 | 73,434 |
| Kennedy Kelly J. | Director | Grant / award | 2026-06-16 | 73,434 |
| Hirsch Douglas Joseph | Director | Grant / award | 2026-06-16 | 73,434 |
| Bruehlman Ronald E | Director | Grant / award | 2026-06-16 | 73,434 |
| Bezdek Trevor | Director | Grant / award | 2026-06-16 | 73,434 |
| Wagner Scott | Director | Grant / award | 2026-06-16 | 73,434 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-15 | Fengler Justin | See Remarks | Option exercise | 32,490 | — |
| 2026-10-15 | Fengler Justin | See Remarks | Tax withholding | 14,247 | $3.38 |
| 2026-10-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 5,793 | — |
| 2026-10-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 2,948 | $3.38 |
| 2026-10-15 | Barnes Wendy Lynn | See Remarks | Option exercise | 115,149 | — |
| 2026-10-15 | Barnes Wendy Lynn | See Remarks | Tax withholding | 50,021 | $3.38 |
| 2026-10-15 | Barnes Wendy Lynn | See Remarks | Option exercise | 51,177 | — |
| 2026-10-15 | Barnes Wendy Lynn | See Remarks | Tax withholding | 22,232 | $3.38 |
| 2026-10-15 | Barnes Wendy Lynn | See Remarks | Option exercise | 110,963 | — |
| 2026-10-15 | Barnes Wendy Lynn | See Remarks | Tax withholding | 48,203 | $3.38 |
| 2026-09-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 2,101 | — |
| 2026-09-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 1,069 | $3.56 |
| 2026-09-15 | Fengler Justin | See Remarks | Option exercise | 2,335 | — |
| 2026-09-15 | Fengler Justin | See Remarks | Tax withholding | 1,024 | $3.56 |
| 2026-09-15 | Fengler Justin | See Remarks | Option exercise | 752 | — |
| 2026-09-15 | Fengler Justin | See Remarks | Tax withholding | 330 | $3.56 |
| 2026-08-26 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 213,401 | $3.51 |
| 2026-08-26 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 210,378 | $3.51 |
| 2026-08-26 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 439,310 | $3.50 |
| 2026-08-26 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 433,088 | $3.50 |
| 2026-08-25 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 64,090 | $3.44 |
| 2026-08-25 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 63,183 | $3.44 |
| 2026-08-24 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 72,309 | $3.46 |
| 2026-08-24 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 71,285 | $3.46 |
| 2026-08-21 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 138,338 | $3.50 |
| 2026-08-21 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 136,379 | $3.50 |
| 2026-08-20 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 233,415 | $3.52 |
| 2026-08-20 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 213,844 | $3.52 |
| 2026-08-19 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Derivative conversion | 4,995,903 | — |
| 2026-08-19 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Derivative conversion | 2,504,097 | — |
| 2026-08-19 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Other acquisition/disposition | 3,596,648 | $0.00 |
| 2026-08-19 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Other acquisition/disposition | 1,142,357 | $0.00 |
| 2026-08-19 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 237,671 | $3.53 |
| 2026-08-19 | FRANCISCO PARTNERS IV, L.P. | Reporting person | Open market sale | 234,304 | $3.53 |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 1,252 | — |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 638 | $3.73 |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 1,686 | — |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 858 | $3.73 |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 2,636 | — |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 1,342 | $3.73 |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 4,541 | — |
| 2026-08-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 2,311 | $3.73 |
| 2026-08-15 | Fengler Justin | See Remarks | Option exercise | 10,149 | — |
| 2026-08-15 | Fengler Justin | See Remarks | Tax withholding | 4,575 | $3.73 |
| 2026-08-15 | Fengler Justin | See Remarks | Option exercise | 6,423 | — |
| 2026-08-15 | Fengler Justin | See Remarks | Tax withholding | 2,817 | $3.73 |
| 2026-08-15 | Fengler Justin | See Remarks | Option exercise | 6,392 | — |
| 2026-08-15 | Fengler Justin | See Remarks | Tax withholding | 2,803 | $3.73 |
| 2026-08-15 | Fengler Justin | See Remarks | Option exercise | 25,568 | — |
| 2026-08-15 | Fengler Justin | See Remarks | Tax withholding | 11,212 | $3.73 |
| 2026-07-15 | McGinnis Christopher A | See Remarks | Option exercise | 36,988 | — |
| 2026-07-15 | McGinnis Christopher A | See Remarks | Tax withholding | 16,294 | $3.01 |
| 2026-07-15 | Barnes Wendy Lynn | See Remarks | Option exercise | 115,148 | — |
| 2026-07-15 | Barnes Wendy Lynn | See Remarks | Tax withholding | 50,021 | $3.01 |
| 2026-07-15 | Barnes Wendy Lynn | See Remarks | Option exercise | 51,177 | — |
| 2026-07-15 | Barnes Wendy Lynn | See Remarks | Tax withholding | 22,232 | $3.01 |
| 2026-07-15 | Barnes Wendy Lynn | See Remarks | Option exercise | 110,963 | — |
| 2026-07-15 | Barnes Wendy Lynn | See Remarks | Tax withholding | 48,203 | $3.01 |
| 2026-07-15 | Chan Thomas (TC) | Chief Accounting Officer | Option exercise | 5,792 | — |
| 2026-07-15 | Chan Thomas (TC) | Chief Accounting Officer | Tax withholding | 2,947 | $3.01 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:34 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-21 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-17 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-17 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
Recent news
Headlines about GDRX (GoodRx Holdings, Inc. Class A). Links open the publisher — we don’t host full articles.
-
GoodRx Holdings And 2 Penny Stocks With Strong Balance Sheets
Yahoo · 2026-10-20 -
GDRX Nov 2026 5.000 put (GDRX261120P00005000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-16 -
GDRX261120P00005000 interactive stock chart | GDRX Nov 2026 5.000 put stock
Yahoo Finance Australia · 2026-10-16 -
GDRX Nov 2026 5.000 call (GDRX261120C00005000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-16 -
GDRX261016C00007500 Interactive Stock Chart | GDRX Oct 2026 7.500 call Stock - Yahoo Finance
Yahoo! Finance Canada · 2026-10-16 -
Amazon (AMZN) and GoodRx (GDRX) Chase Prescription Subscribers as Insurance Coverage Slips
Yahoo Finance · 2026-10-01 -
1 Value Stock to Target This Week and 2 That Underwhelm
Yahoo Finance · 2026-09-29 -
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
Yahoo Finance · 2026-08-14
No headlines in this category right now — try “All”.